eXmoor Pharma operates as a full-service Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO), leveraging over 20 years of consultancy experience to support the development of novel therapies. The company specializes in providing comprehensive solutions throughout the entire development journey, from early process development and scale-up to Good Manufacturing Practice (GMP) manufacturing, fill and finish, and Qualified Person (QP) release. Their state-of-the-art facility spans 65,000 square feet and is equipped with GMP clean rooms and fill-finish capabilities specifically designed for viral vectors, autologous and allogenic cell therapies, as well as RNA technologies.

The company emphasizes a collaborative approach, working closely with clients to de-risk projects and enhance the likelihood of product success. eXmoor Pharma has successfully completed over 500 projects for more than 150 clients in the cell therapy and biopharma sectors, showcasing their extensive expertise and commitment to innovation. Their team, which boasts around 500 years of combined experience, is dedicated to knowledge sharing and operational excellence, ensuring that their services align with clients' business strategies and project needs.

United Kingdom

eXmoor is a full service Cell & Gene Therapy CDMO with a difference.  We are backed by 20 years consultancy experience supporting over 150 organisations accelerate novel therapies from discovery to patients.

We provide expert solutions at all stages of the development journey from early process development and scale-up through to GMP manufacture, fill and finish and QP release. 

We are open, transparent and will work with you at every step to de-risk and streamline your project and maximise the chances of product success.

eXmoor Pharma

Company Details